Atossa Net Receivables from 2010 to 2026

ATOS Stock  USD 0.64  0.01  2.17%   
Atossa Genetics Net Receivables yearly trend continues to be comparatively stable with very little volatility. Net Receivables is likely to outpace its year average in 2026. From the period from 2010 to 2026, Atossa Genetics Net Receivables quarterly data regression had r-value of (0.50) and coefficient of variation of (1,322). View All Fundamentals
 
Net Receivables  
First Reported
2011-12-31
Previous Quarter
-1.4 M
Current Value
-1.1 M
Quarterly Volatility
520.3 K
 
Yuan Drop
 
Covid
Check Atossa Genetics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Atossa Genetics' main balance sheet or income statement drivers, such as Other Operating Expenses of 33.4 M, Research Development of 17 M or Total Operating Expenses of 33.4 M, as well as many indicators such as Price To Sales Ratio of 7.6 K, Dividend Yield of 0.0 or PTB Ratio of 1.82. Atossa financial statements analysis is a perfect complement when working with Atossa Genetics Valuation or Volatility modules.
  
Build AI portfolio with Atossa Stock
Check out the analysis of Atossa Genetics Correlation against competitors.
For more information on how to buy Atossa Stock please use our How to Invest in Atossa Genetics guide.

Latest Atossa Genetics' Net Receivables Growth Pattern

Below is the plot of the Net Receivables of Atossa Genetics over the last few years. It is Atossa Genetics' Net Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Atossa Genetics' overall financial position and show how it may be relating to other accounts over time.
Net Receivables10 Years Trend
Slightly volatile
   Net Receivables   
       Timeline  

Atossa Net Receivables Regression Statistics

Arithmetic Mean(66,345)
Geometric Mean246,847
Coefficient Of Variation(1,322)
Mean Deviation680,021
Median141,665
Standard Deviation877,340
Sample Variance769.7B
Range2.7M
R-Value(0.50)
Mean Square Error619.3B
R-Squared0.25
Significance0.04
Slope(86,114)
Total Sum of Squares12.3T

Atossa Net Receivables History

2026-1.6 M
2025-1.6 M
2023-1.4 M
2022743 K
20211.1 M
2020634.9 K
2019739.7 K

About Atossa Genetics Financial Statements

Atossa Genetics shareholders use historical fundamental indicators, such as Net Receivables, to determine how well the company is positioned to perform in the future. Although Atossa Genetics investors may analyze each financial statement separately, they are all interrelated. The changes in Atossa Genetics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Atossa Genetics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Net Receivables-1.6 M-1.6 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Atossa Stock Analysis

When running Atossa Genetics' price analysis, check to measure Atossa Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atossa Genetics is operating at the current time. Most of Atossa Genetics' value examination focuses on studying past and present price action to predict the probability of Atossa Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atossa Genetics' price. Additionally, you may evaluate how the addition of Atossa Genetics to your portfolios can decrease your overall portfolio volatility.